Update on our study of an early treatment COVID-19

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial Eric J. Lenze, MD1; Caline Mattar, MD2; Charles F. Zorumski, MD1; Angela Stevens, BA1; Julie Schweiger1; Ginger E. Nicol, MD1; J. Philip Miller, AB3; Lei Yang, MPH, MSIS1; Michael Yingling, MS1; Michael S. Avidan, MBBCh4; Angela M. Reiersen, MD, MPE1JAMA. Published online November 12, 2020. doi:10.1001/jama.2020.22760

Jennifer Blome of 550 KTRS interviews Dr. Lenze

In honor of Mental Health Awareness Month, we shared information about our healthy aging studies for adults ages 60+ on-air with Jennifer Blome of The Big 550 KTRS. Listen to the full recording or read the transcript below. TRANSCRIPT This radio interview aired on May 14, 2018. Jennifer Blome (The Big 550 KTRS): There is […]

Psychotropic Drugs and Falls in Older Adults (Links to an external site)

In the elderly, falls are a common and important problem. One of the most feared consequences of falling is a hip fracture. Other consequences include other fractures, head injuries, and less serious injuries that can nonetheless impair function and quality of life.

Hard-to-treat depression in seniors focus of $13.5 million study (Links to an external site)

“Older adults who are prescribed antidepressants often find that they don’t get better with the first or second medication they are prescribed,” said principal investigator Eric J. Lenze, MD, a professor of psychiatry. “So what should they get? This will be the largest and, we hope, the definitive study to answer that question. This study will show us which treatments work best and which are safest, and it will help us personalize treatment.”